Enfermedades Infecciosas

Biezma, MI; Munoz, P; De la Villa, S; Farinas-Alvarez, MC; de las Revillas, FA; Gutierrez-Carretero, E; De Alarcon, A; Rodriguez-Garcia, R; Llopis, J; Goenaga, MA; Gutierrez-Villanueva, A; Plata, A; Vidal, L; Martinez-Selles, M.

Infective Endocarditis in Diabetic Patients: A Different Profile with Prognostic Consequences

Journal of Clinical Medicine. 2022; 11(9): Nº de citas: 10 [doi:10.3390/jcm11092651]

Galan-Martinez, J; Stamatakis, K; Sanchez-Gomez, I; Vazquez-Cuesta, S; Girones, N; Fresno, M.

Isoform-specific effects of transcription factor TCFL5 on the pluripotency-related genes SOX2 and KLF4 in colorectal cancer development

MOLECULAR ONCOLOGY. 2022; 16(9): 1876-1890 Nº de citas: 2 [doi:10.1002/1878-0261.13085]

Aguilera-Alonso, D; Nieto, SK; Montojo, MFA; Santaeufemia, FJS; Saavedra-Lozano, J; Soto, B; Caminoa, MB; Berzosa, A; Tato, LP; Cercenado, E; Tagarro, A; Arana, DM; Sanz, MA; Gomez, MPR; Sanchez, FC; Baquero-Artigao, F.

Staphylococcus aureus Community-acquired Pneumonia in Children After 13-Valent Pneumococcal Vaccination (2008-2018): Epidemiology, Clinical Characteristics and Outcomes

PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2022; 41(5): 235-242 Nº de citas: 8 [doi:10.1097/INF.0000000000003503]

Pulido-Perez, A; Sanchez-Carrillo, C; Bergon-Sendin, M; Suarez-Fernandez, R; Rosell-Diaz, AM; Munoz, P; Bouza, E.

Prevalence and clinical features of secondary skin lesions in septic patients with bloodstream infections

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2022; 41(5): 779-786 Nº de citas: 1 [doi:10.1007/s10096-022-04431-6]

Guembe, MG; Pensado, YT; Picado, FT; Diez, C; Latorre, LP; Fanciulli, C; Vazquez, FP; de Quiros, JCLB; Berenguer, J; Ortega, BP; Machado, M; Minero, MV; Garcia, PM; Santiago, EB; Galar, A; Catalan, P; Alonso, R; Bellon, JM; Lois, TAE; Gregorio Maranon Microbiology-ID.

SARS-COV-2 Infection in People Living with HIV: Experience from a Tertiary Hospital in Madrid

AIDS RESEARCH AND HUMAN RETROVIRUSES. 2022; 38(5): 394-398 Nº de citas: 4 [doi:10.1089/aid.2021.0159]

Campoy PJS; Buenestado-Serrano S; Pérez-Lago L; Rodriguez-Grande C; Catalán P; Andrés-Zayas C; Alcalá L; Losada C; Rico-Luna C; Muñoz P; de Viedma DG.

First importations of SARS-CoV-2 P.1 and P.2 variants from Brazil to Spain and early community transmission

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2022; 40(5): 262-265 Nº de citas: 5 [doi:10.1016/j.eimc.2021.05.008]

Jbara, S; Herranz, M; Sola-Campoy, PJ; Rodriguez-Grande, C; Chiner-Oms, A; Comas, I; Munoz, P; de Viedma, DG; Perez-Lago, L.

Overlapping prison/community tuberculosis outbreaks in Costa Rica revealed by alternative analysis of suboptimal material

TRANSBOUNDARY AND EMERGING DISEASES. 2022; 69(3): 1065-1072 [doi:10.1111/tbed.14063]

Zvezdanova, ME; Escribano, P; Guinea, J; Munoz, P; Rodriguez-Temporal, D; Rodriguez-Sanchez, B.

Evaluation of the Vitek Ms system for the identification of filamentous fungi

MEDICAL MYCOLOGY. 2022; 60(4): Nº de citas: 10 [doi:10.1093/mmy/myac027]

Caston, JJ; Cano, A; Perez-Camacho, I; Aguado, JM; Carratala, J; Ramasco, F; Soriano, A; Pintado, V; Castelo-Corral, L; Sousa, A; Farinas, MC; Munoz, P; De Medrano, VAL; Sanz-Pelaez, O; Los-Arcos, I; Gracia-Ahufinger, I; Perez-Nadales, E; Vidal, E; Doblas, A; Natera, C; Martinez-Martinez, L; Torre-Cisneros, J.

Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(5): 1452-1460 Nº de citas: 46 [doi:10.1093/jac/dkac049]

Burillo, A; Candel, FJ; Canut-Blasco, A.

Value of syndromic panels in the management of severe community-acquired pneumonia

REVISTA ESPANOLA DE QUIMIOTERAPIA. 2022; 35: 15-20

Carrera-Salinas A; González-Díaz A; Vázquez-Sánchez DA; Camoez M; Niubó J; Càmara J; Ardanuy C; Martí S; Domínguez MÁ.

Staphylococcus aureus surface protein G (sasG) allelic variants: correlation between biofilm formation and their prevalence in methicillin-resistant S. aureus (MRSA) clones

RESEARCH IN MICROBIOLOGY. 2022; 173(3): 103921-103921 Nº de citas: 9 [doi:10.1016/j.resmic.2022.103921]

Bouza E; Arribas JR; Alejos B; Bernardino JI; Coiras M; Coll P; Del Romero J; Fuster MJ; Górgolas M; Gutiérrez A; Gracia D; Hernando V; Martínez-Picado J; Martínez Sesmero JM; Martínez E; Moreno S; Mothe B; Navarro ML; Podzamczer D; Pulido F; Ramos JT; Ruiz-Mateos E; Suárez García I; Palomo E.

Past and future of HIV infection. A document based on expert opinion

REVISTA ESPANOLA DE QUIMIOTERAPIA. 2022; 35(2): 131-156 Nº de citas: 6 [doi:10.37201/req/083.2021]

Bouza, E; Burillo, A.

Current international and national guidelines for managing skin and soft tissue infections

CURRENT OPINION IN INFECTIOUS DISEASES. 2022; 35(2): 61-71 Nº de citas: 7 [doi:10.1097/QCO.0000000000000814]

Calero, AL; Alonso, R; Gadea, I; Vega, MDM; Garcia, MM; Munoz, P; Machado, M; Bouza, E; Garcia-Rodriguez, J.

Comparison of the Performance of Two Galactomannan Detection Tests: Platelia Aspergillus Ag and Aspergillus Galactomannan Ag Virclia Monotest

Microbiology spectrum. 2022; 10(2): Nº de citas: 24 [doi:10.1128/spectrum.02626-21]

Prattes, J; Wauters, J; Giacobbe, DR; Salmanton-Garcia, J; Maertens, J; Bourgeois, M; Reynders, M; Rutsaert, L; Van Regenmortel, N; Lormans, P; Feys, S; Reisinger, AC; Cornely, OA; Lahmer, T; Valerio, M; Delhaes, L; Jabeen, K; Steinmann, J; Chamula, M; Bassetti, M; Hatzl, S; Rautemaa-Richardson, R; Koehler, P; Lagrou, K; Hoenigl, M.

Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology

CLINICAL MICROBIOLOGY AND INFECTION. 2022; 28(4): 580-587 Nº de citas: 175 [doi:10.1016/j.cmi.2021.08.014]

Fresco-Taboada, A; Garcia-Duran, M; Aira, C; Lopez, L; Sastre, P; van der Hoek, L; van Gils, MJ; Brouwer, PJM; Sanders, RW; Holzer, B; Zimpernikc, I; Lopez-Collazo, E; Munoz, P; Rueda, P; Vela, C.

Diagnostic performance of two serological assays for the detection of SARS-CoV-2 specific antibodies: surveillance after vaccination

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2022; 102(4): Nº de citas: 4 [doi:10.1016/j.diagmicrobio.2022.115650]

Sivori, F; Cavallo, I; Kovacs, D; Guembe, M; Sperduti, I; Truglio, M; Pasqua, M; Prignano, G; Mastrofrancesco, A; Toma, L; Pimpinelli, F; Morrone, A; Ensoli, F; Di Domenico, EG.

Role of Extracellular DNA in Dalbavancin Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms in Patients with Skin and Soft Tissue Infections

Microbiology spectrum. 2022; 10(2): Nº de citas: 27 [doi:10.1128/spectrum.00351-22]

Burillo, A; Bouza, E.

Faster infection diagnostics for intensive care unit (ICU) patients

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2022; 22(3): 347-360 Nº de citas: 3 [doi:10.1080/14737159.2022.2037422]